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 Abstract 
 
Background: The aging rate is highest in Japan in the world, especially in female population.  
To explore the trend of acute myocardial infarction (AMI) in Japan, the MIYAGI-AMI 
Registry Study for 30 years since 1979 has been performed, where all AMI patients are 
prospectively registered in the Miyagi prefecture.  
Methods and Results: In 1979-2008, 22,551AMI patients (male/female 16,238/6,313) were 
registered from the 43 hospitals.  The age-adjusted incidence of AMI (/100,000 
persons/year) increased from 7.4 in 1979 to 27.0 in 2008 (P<0.001), where the control of 
coronary risk factors remained insufficient.  The rates of ambulance use and primary 
percutaneous coronary intervention (PCI) have increased, and the overall in-hospital 
mortality (age-adjusted) decreased from 20.0% in 1979 to 7.8% in 2008 (P<0.0001).  
However, the in-hospital mortality remains relatively higher in female than in male patients 
(12.2% vs. 6.3% in 2008).  The female patients were characterized by higher age and lower 
PCI rate.  
Conclusions: The MIYAGI-AMI Registry Study demonstrates the steady trend of the 
increasing incidence but decreasing mortality of AMI over the last 30 years, where female 
population still remains at higher risk for in-hospital death of AMI, despite of the 
improvement of ambulance use and primary PCI. 
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Introduction 
 
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide.  
Indeed,  the data and statistics from World Health Organization demonstrated that ischemic 
heart disease is the leading cause of death (7.2 per million; 12.2% of total death) and expects 
to be increasing by 2030
1)
.   Also, in the United States, nearly 1 million patients suffer from 
AMI each year.
2)  For the past decades, industrialization, urbanization, and associated 
life-style changes have taken place worldwide, as the population grows older in association 
with the epidemics of obesity and metabolic syndrome.  Especially, in Japan, these changes 
have become more evident because the rate of aging is the highest in the world and the 
westernization of lifestyle progresses rapidly.
3)
  In order to estimate the trends in the burden 
of disease, particularly that of AMI, it is important to monitor and track the incidence and 
mortality of AMI in the same community for a long time.  Indeed, the World Health 
Organization Monitoring Trends and Determinants in Cardiovascular Disease 
(WHO-MONICA) project reported prevalence and case-fatality rate in 21 countries,
4)
 in 
which project, however, Japan was not included.  Moreover, in Japan, there have been few 
studies specific for AMI and most of them included a small number of annual events with a 
relatively short monitoring period.
5)-8)
  
 To explore the actual trend of AMI reflecting “real-world” practice in Japan, The 
MIYAGI-AMI Registry Study for 30 years since 1979 has been performed, where all AMI 
patients have been prospectively registered in Miyagi prefecture with a relatively stable 
population over those years.
9),10)
  In the present study, it is reported the first results of the 
MIYAGI-AMI Registry Study over the last 30 years, demonstrating the actual increasing 
incidence but decreasing mortality of AMI in Japan and that female patients are at higher risk 
than male patients.   
Methods 
 
The MIYAGI-AMI Registry Study 
The Miyagi prefecture is located in northeastern Japan and has a relatively stable population 
of approximately 2 million over the last 30 years (2,054,000 in 1979 and 2,340,000 in 2008).  
The MIYAGI-AMI Registry Study is a prospective, multi-center, observational study.  
Details of data collection have been published previously.
9),10)
  Briefly, this registry was 
established in 1978 and the 43 major hospitals with coronary care unit and/or cardiac 
catheterization facilities in the Miyagi prefecture have been participating (Appendix).  In 
our study, almost all the patients with AMI in the Miyagi prefecture were finally admitted to 
one of the 43 participating hospitals, enabling us to precisely examine the practice for AMI in 
the Miyagi prefecture.  This study was approved by the Institutional Review Board of 
Tohoku University Graduate School of Medicine, under the condition that personal data are 
protected at all times.  
Diagnosis of AMI was made by an individual cardiologist in charge, based on the 
WHO-MONICA criteria.
4)
  Generally, it was based on the findings of typical chest pain 
symptoms, ECG changes and increased serum levels of cardiac enzymes (i.e. creatine 
phosphokinase, aspartate aminotransferase and lactate dehydrogenase).  
The registration form included the date and time of symptom onset, age, sex, 
pre-hospital management (e.g. use of ambulance, time interval from the onset of symptoms to 
admission), infarction site, coronary risk factors (hypertension, diabetes mellitus, 
dyslipidemia, and smoking), reperfusion therapies [e.g. thrombolysis or percutaneous 
coronary intervention (PCI)], duration of hospitalization and in-hospital outcome (e.g. 
in-hospital mortality).  In the Miyagi-AMI Registry Study, the registration form has been 
revised step by step in the last 30 years.  Thus, although the incidence of AMI and related 
data (time of onset, age and sex) are available for the last 30 years, the date on the 
pre-hospital management, infarction site, coronary risk factors, reperfusion therapies, 
duration of hospitalization, and in-hospital outcome are available for the last 10-20 years.   
In the Miyagi-AMI Registry Study, the decision of reperfusion was made by an 
individual cardiologist in charge.  Primary PCI was commonly performed since 1992 in this 
registry, according to the protocol of each hospital.  Thrombolysis was performed with 
intravenous administration of urokinase (480~960 x 10
3
 IU for 30 min) or alteplase (290~435 
x 10
3 
IU/kg for 60 min), or with intracoronary administration of alteplase (maximum 6.4 x 
10
6 
IU) or urokinase (maximum 960 x 10
3
 IU).
3),4)
  Rescue PCI was performed when 
thrombolysis was unsuccessful in terms of symptoms, ECG changes and/or coronary blood 
flow. 
 
Data analysis  
In the present study, we have registered a total of 22,551 patients with AMI (male/female 
16,238/6,313) who were hospitalized between 1979 and 2008.  Gender- and age-adjusted 
incidence rate of AMI per 100,000 person-years were calculated.  To adjust the age 
distribution differences among the periods, the direct method using the Japanese population 
from 2000 census
11)
 was applied, as the standard populations. 
 Results are expressed as mean ± SD.  Trend in age-adjusted incidence, 
age-adjusted in-hospital mortality, and use of ambulance were assessed using the 
Cochran-Armitage trend test.
12),13)
  Age and therapy differences were estimated by using the 
χ
2-test.  Factors associated in-hospital mortality that were found to be significant in 
preliminary univariate analysis were then simultaneously included in a multivariate logistic 
regression.  These analyses were carried out with the SAS software version 9.1 (SAS 
Institute, Inc, Cary, NC).  P-values <0.05 were considered to be statistically significant.   
Results 
 
The overall crude incidence of AMI (/100,000 persons/ year) increased by 4.6 fold, from 9.4 
in 1979 to 42.9 in 2008 (p<0.001) (Figure 1).  The overall age-adjusted incidence of AMI 
(/100,000 persons/year) markedly increased by 3.6 fold, from 7.4 in 1979 to 27.0 in 2008 
(P<0.001) (Figure 2).  The average age of the male and female AMI patients in the whole 
period was 65±13 and 75±11 years, respectively.  In male, the age-adjusted incidence of 
AMI (/100,000 persons/year) significantly increased by 2.5 fold, from 18.7 in 1979 to 46.4 in 
2008 (P<0.0001), whereas in female, it tended to be increased by 2.3 fold, from 4.2 in 1979 
to 9.6 in 2008, but did not reach a statistical significant level (P=0.15).  
 The distribution of age was significantly changed with increased population of 
elderly patients, especially that of ≥80-year-old patients, in both genders (both P<0.001) 
(Figure 3).  Moreover, the prevalence of hypertension, diabetes mellitus, and dyslipidemia 
also significantly increased over the time in both genders (all P<0.01) (Figure 4).  Smoking 
habit also remained at ~40% in male and ~10% in female patients (Figure 4).  The peak 
onset time of AMI remained in the early morning (Figure 5), as in the case of the distribution 
of infarct site (anterior wall in 45%, inferior/posterior wall in 43%, and others in 12%).  
 Over the last 30 years, the use of ambulance significantly increased from 47% in 
1980 to 64% in 2008 (P<0.0001) (Figure 6).  Along with this increased use of ambulance, 
the overall in-hospital mortality has markedly decreased from 20% in 1979 to 8% in 2008 
(P<0.0001) (Figure 6).  However, the in-hospital mortality remained relatively higher in the 
female patients than in the male patients over the last 30 years (6% in male and 12% in 
female in 2008) (Figure 6).  The logistic analysis of 10,415 patients registered between 
1998 and 2008 demonstrated that diabetes mellitus (Odds ratio, 1.21; 95% confidence 
interval, 1.04 to 1.40; P=0.01), female (Odds ratio, 1.64; 95% confidence interval, 1.07 to 
2.53; P=0.024) and body surface area (Odds ratio, 1.09; 95% confidence interval, 0.46 to 
0.86; P=0.004) were significantly associated with in-hospital mortality. 
 Application of primary PCI has dramatically increased from 20% in 1992 to 80% in 
2008 (P<0.0001) (Figure 7).  In contrast, the prevalence of patients without reperfusion 
therapy significantly decreased from 38% in 1992 to 18% in 2008 (P<0.0001).  In-hospital 
mortality in the PCI era (between 1997 and 2008) was significantly lower in patients with 
primary PCI (5%, n=8,693) than in that without it (17%, n=254) (P<0.01), which was 
comparable with in-hospital mortality (14%) in the pre-PCI era (between 1979 and 1996) 
(Figure 8).  Importantly, the prevalence of primary PCI was significantly lower in the 
female patients (71%, n=2,412) than in the male patients (80%, n=6,061) (P<0.01) (Figure 
9).  
In 1979, approximately 30% of patients needed more than 12 hours from the onset 
of AMI to hospitalization, while 60% of patients were hospitalized within 6 hours after the 
onset (Figure 10).  This tendency that the majority of AMI patients were hospitalized within 
6 hours was fairly consistent throughout the study period (Figure 10).  
Finally, the duration of hospital stay has been significantly shortened over the last 30 
years; the prevalence of discharge within 20 days after the onset of AMI significantly 
increased from 20% in 1979 to 66% in 2008 (P<0.0001) (Figure 11). 
Discussion 
 
The 30-year MIYAGI-AMI Registry Study demonstrates that there is the steady trend of the 
increasing incidence but decreasing mortality of AMI and that female population still remains 
at higher risk for in-hospital mortality, despite of the progress of transfer-system and 
reperfusion therapy.  
 
Increasing Incidence of AMI  
There have been few studies regarding the incidence of AMI in Japan and most of them were 
performed between 1960’s and 1980’s.
5),14),15)
  These studies seem to be conflicting as they 
reported the declining
14)
 or flattened
5),15)
 trend of the incidence of AMI.  After 1990’s, the 
rate of aging has been the highest in Japan in the world and the life-style westernization has 
rapidly accelerated, however, no detailed data have yet been available regarding the actual 
incidence and outcome of AMI.   
The study of Hisayama, a farming community adjoining Fukuoka City in Kyushu 
Island, Japan, is a population-based study that has established 3 study cohorts in 1961 (1618 
subjects, first cohort), 1974 (2038 subjects, second cohort), and 1988 (2637 subjects, third 
cohort)
 17)
.  The age-adjusted incidence of AMI did not significantly change among the 
cohorts for male (219, 243 and 154) and female (66, 89 and 87). 
Miyagi prefecture is located on the Pacific Ocean site of Japan and is endowed with 
typical balance between urban and rural districts.  The MIYAGI-AMI Registry Study 
provides important insights into the last 30-year trend of AMI in Japan from 1979 to 2008.  
The overall crude incidence of AMI (/100,000 persons/ year) increased by 4.6 fold, from 9.4 
in 1979 to 42.9 in 2008 (P<0.01) (Figure 1), and the overall age-adjusted incidence of AMI 
(/100,000 persons/year) increased from 7.4 in 1979 to 27.0 in 2008 (Figure 2), indicating the 
steady trend of the increasing incidence of AMI.  The incidence of AMI significantly 
increases over time even if the increasing residences in Miyagi prefecture are replaced with 
Japanese model population.  The incidence of AMI was male-predominant (male 46.4 vs. 
female 9.6 in 2008), a consistent finding with the Takashima AMI registry (male 100.7 vs. 
female 35.7 in 1999-2001)
6)
 and the Niigata and Nagaoka study (male 41.9 vs. female 5.3 in 
1994-1996).
7)
  However, the current incidence of AMI in Japan is still lower than that in 
North America and Europe; the incidence of AMI for male (/100,000 persons/year) is 824 in 
Finland, 823 in United Kingdom, 605 in Canada, 508 in the United States, 314 in France, and 
270 in Italy.
16)
   
Age is one of the most important risk factors for development of cardiovascular 
diseases and accompanying clinical events.  In the present study, the aging of the population 
is evident; the number of aged patients, especially that of ≥80-year-old patients, increased 
significantly in the last 30 years (Figure 3).  Even relatively short-term period survey 
(1992–2001) of the Medicare in 4 US states demonstrated that the age of AMI patients 
became older and that the proportion of the population > 85-year-old was increased.
19)
  
These findings indicate
 
the urgent need for evidence-based management strategies applicable
 
to increasingly elderly AMI patients.
18)
  
 
Insufficient Control of Coronary Risk Factors 
The WHO-MONICA studies as well as the Japanese epidemiological studies have previously 
shown that the risk of cardiovascular diseases increases with clustering of risk factors, such 
as hypertension, hyperlipidemia and diabetes mellitus.
21)-23)
  The present study demonstrates 
that the control of major coronary risk factors is still insufficient in Japan (Figure 4), which 
could largely account for the increasing incidence of AMI.  The westernization of life-style 
and the high rate of aging in Japan are apparent causative factors for the trend.  Furthermore, 
the prevalence of smoking habits still remains high at ~40% in male patients with AMI, 
although it has been reported that the smoking rate has been declined by 20% in general 
population in Japan.
24),26)
  
 
Female at Higher Risk for In-hospital Mortality of AMI 
One of the important findings in the present study is that the in-hospital mortality still 
remains relatively higher in female patients than in male patients (Figure 6).  Similar trend 
has been reported from the American Heart Association Heart Disease and Stroke 
Statistics.
26)
  The logistic analysis also revealed that female and smaller body surface area 
were significantly associated with in-hospital mortality.  Several factors could be involved 
in the gender difference in the in-hospital mortality of AMI, including higher age, longer 
elapsing time from onset to hospitalization, and low prevalence of PCI in female AMI 
patients.  Indeed, in the present study, the average age of the female patients was 10 years 
older than that of the male patients.  The older age of female patients at the time of 
admission may further limit the use of several therapies,
27)
 which could have been the case in 
the present study.  In addition, the incidence of death from procedural complications, such 
as vascular and hemorrhagic complications, is greater in female.
28)
  Thus, much attention 
should be paid to these factors when treating female AMI patients.   
 
Unchanged Onset Time and Infarct Site of AMI 
It has been repeatedly demonstrated that the onset of AMI peaks early in the morning in 
Japan
29)
 and western countries.
30), 31)
  The present study not only confirmed this point but 
also demonstrated that such tendency has unchanged for the last 20 years (Figure 5).  These 
results suggest that the triggering mechanism(s) for AMI has remained unchanged despite the 
increasing incidence of the disease.    
The present study also demonstrated that the prevalence of AMI site has unchanged 
in the last 30 years.  Although anterior AMI is associated with worse outcome as compared 
with inferior AMI,
32)
 the present result indicates that the improvement of morality is likely to 
be related to factors other than AMI site in the present study. 
 
Improvement of Critical Care and In-Hospital Care for AMI 
The present study demonstrated the overall in-hospital mortality (age-adjusted) has been 
significantly reduced from ~20% in 1979 to 12.2% in 2008.  The duration of hospital stay 
was also significantly shortened over the last 30 years (Figure 11), when the paradigm of 
AMI management has shifted from conservative strategy to interventional strategy.
33)
  In 
fact, in the present study, application of primary PCI has been increasing from 20% in 1992 
to ~80% in 2008 (Figure 7), and in-hospital mortality was lower in patients who underwent 
primary PCI than in those who did not (Figure 9).  The progress of reperfusion therapy, 
especially that of primary PCI, appears to contribute to the reduction in in-hospital mortality 
and hospital stay, as previously reported from this registry.
9),10)
   
Currently, approximately a half of AMI patients are transported by ambulance in the 
western countries.
34),35)
  The present study demonstrated the ambulance use has been 
increased to ~70% in the last 10 years in Japan (Figure 6).  Since the majority of AMI 
patients were hospitalized within 6 hours in the last 30 years (Figure 10), the increased use of 
ambulance may not have directly contributed to the shortened interval from onset of 
symptoms to hospitalization.  However, the increased use of ambulance should have 
resulted in the increased application of primary PCI with a resultant improvement of 
in-hospital mortality.   
The increasing incidence but decreasing in-hospital mortality of AMI may have 
resulted in the recent increase in the number of patients with ischemic heart failure in Japan, 
as reported in the Chronic Heart Failure Analysis and Registry in the Tohoku District 
(CHART) registry study.
36)
  For survived AMI patients, it is important to understand the 
underlying risk factors that lead to secondary cardiac events.
35)
  Indeed, more effective 
strategy to improve the management of post-infarction heart failure needs to be 
developed.
36),37)
 
 
 
Study Limitations 
Several limitations should be mentioned for the present study.  First, the present study did 
not include patients with out-of-hospital cardiac arrest.  Since acute myocardial infarction) 
are the major underlying causes of out-of-hospital cardiac arrest
38)
, a possibility remains that 
the crude incidence of AMI and in-hospital mortality may be underestimated.  Second, 
management decisions (e.g., reperfusion therapy, medical treatment including risk factors 
control) were left to the discretion of each attending physician.  Third, the diagnosis of AMI 
has been improving over years
39)
.  Indeed, troponins are widely used in the recent clinical 
practice because they are more sensitive and specific biomarkers of myocyte necrosis than 
creatine kinase
40)
. 
 
Conclusions 
The MIYAGI-AMI Registry Study demonstrates that over the last 30 years, there is the 
steady trend of increasing incidence but decreasing mortality of AMI in Miyagi prefecture, 
where female patients still are at higher risk for in-hospital mortality than male patients, for 
which the positive factors (e.g. increased use of ambulance and primary PCI) and the 
negative factors (e.g. insufficient control of coronary risk factors and the aging of the whole 
society) may be involved.   
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Appendix.  List of participating hospitals  
Fukaya Hospital, Hiroshi Akiho, MD. 
Hikarigaoka Spellman Hospital, Tomofumi Mimata, MD. 
Ishinomaki Municipal Hospital, Kenjirou Akai, MD. 
Ishinomaki Red-Cross Hospital, Hiroyasu Sukegawa, MD. 
JR Sendai Hospital, Masao Kuroha , MD. 
Katta General Hospital, Hiroyuki Kanno, MD.  
Kesen-numa Hospital, Kazunori Ogata, MD. 
Kurihara Central Hospital, Seiji Komatsu, MD. 
Tohoku Rosai Hospital, Tatsuya Komaru, MD. 
Marumori National Health Insurance Hospital, Masataka Otomo, MD. 
Miyagi Eastern Cardiovascular Institute, Toru Naganuma, MD. 
Miyagi Cancer Center, Nobuo Tomisawa, MD. 
Miyagi Cardiovascular and Respiratory Center, Noboru Osawa, MD. 
Mori Hospital, Akio Mori, MD. 
Nagamachi Hospital, Hidetoshi Mitobe, MD. 
Nishitaga National Hospital, Shigenori Kitaoka, MD. 
NTT EAST Tohoku Hospital, Aki Yamada, MD. 
Oizumi Memorial Hospital, Yoshirou Koiwa, MD. 
Osaki Citizen Hospital, Tetsuya Hiramoto, MD. 
Saito Hospital, Keiji Otsuka, MD. 
Saka General Hospital, Atsushi Obata, MD. 
Sanuma Municipal General Hospital, Hiroshi Ishii, MD. 
Sendai Cardiovascular Center, Shin-ya Fujii, MD. 
Sendai City Hospital, Tetsuo Yagi, MD. 
Sendai Kosei Hospital, Taiichirou Meguro, MD. 
Sendai Medical Center, Tsuyoshi Shinozaki, MD. 
Sendai Open Hospital, Masaharu Kanazawa, MD. 
Sendai Public Health Insurance Hospital, Yoshichika Oikawa, MD. 
Sendai Red-Cross Hospital, Yuji Konno, MD. 
Sendai Tokushukai Hospital, Kimihiko Ogata, MD. 
Sen-en General Hospital, Ryouichi Hashiguchi, MD. 
Shichigashuku National Health Insurance Clinic, Takahiro Nagashima T, MD. 
Shiogama City Hospital, Jun Goto, MD. 
South Miyagi Medical Center, Kan-ichi Inoue, MD. 
Tohoku Kosai Hospital, Mitsumasa Fukuchi, MD. 
Tohoku University Hospital,  
   Department of Cardiovascular Medicine, Hiroaki Shimokawa, MD.  
   Department of Cardiovascular Surgery, Kouichi Tabayashi, MD.  
   Department of Gastroenterology, Toru Shimosegawa, MD. 
Tohoku Welfare and Pension Hospital, Yoshiaki Katahira, MD. 
Tome Public Hospital, Munehiko Ishii, MD. 
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Figure 1.  The crude incidence of AMI (/100,000 persons/ year) increased from 1979 to 
2008. 
The overall crude incidence of AMI (/100,000 persons/ year) increased by 4.6 fold, from 9.4 in 
1979 to 42.9 in 2008 (p<0.001). 
  
 
Figure 2.  The incidence of AMI (/100,000 persons/ year) increased from 1979 to 2008. 
The overall age-adjusted incidence of AMI (/100,000 persons/ year) increased by 3.6 fold, from 
7.4 in 1979 to 27.0 in 2008 (p<0.001). In male, the age-adjusted incidence of AMI (/100,000 
persons/ year) increased by 2.5 fold, from 18.7 in 1979 to 46.4 in 2008 (p<0.0001). In female, 
it increased by 2.3 fold, from 4.2 in 1979 to 9.6 in 2008 (p=0.15). 
  
Figure 3.  The distribution of age was changed with increased population of elderly 
patients. 
The number of aged patients, especially that of ≥80-year-old patients, increased significantly 
in the last 30 years, in both genders (both p<0.001).  
  
Figure 4.  The present study demonstrates that the control of major coronary risk 
factors is still insufficient in Japan.  
Smoking habit also remained at ~40% in male and ~10% in female patients.
  
 
Figure 5.  The peak onset time of AMI remained in the early morning. 
The present study not only confirmed this point but also demonstrated that such tendency has 
unchanged for the last 20 years.  These results suggest that the triggering mechanism(s) for 
AMI has remained unchanged despite the increasing incidence of the disease.
  
 
Figure 6.  The use of ambulance has been increased to ~70%, and the in-hospital 
mortality has been decreased over the last 30 years in Miyagi prefecture. 
The use of ambulance significantly increased from 47% in 1980 to 64% in 2008 (p<0.0001). 
Along with this increased use of ambulance, the overall in-hospital mortality has markedly 
decreased from 20% in 1979 to 8% in 2008 (P<0.0001). However, the in-hospital mortality 
remained relatively higher in the female patients than in the male patients over the last 30 
years (6% in male and 12% in female in 2008).
  
 
Figure 7.  Prevalence of reperfusion therapy for AMI in Miyagi prefecture. 
Primary PCI was commonly performed since 1992 in this registry, according to the protocol 
of each hospital.  Application of primary PCI has dramatically increased from 20% in 1992 
to 80% in 2008 (P<0.0001). The prevalence of patients without reperfusion therapy 
significantly decreased from 38% in 1992 to 18% in 2008 (P<0.0001). The prevalence of 
primary PCI was significantly lower in the female patients (71%, n=2,412) than in the male 
patients (80%, n=6,061) (P<0.01). 
PCI; percutaneous coronary intervention. 
  
 
Figure 8.  The difference in in-hospital mortality among the patients with and without 
primary PCI in the PCI era (between 1997 and 2008) and those in the pre-PCI era 
(between 1979 and 1996). 
In-hospital mortality in the PCI era (between 1997 and 2008) was significantly lower in 
patients with primary PCI than in that without it, which was comparable with in-hospital 
mortality in the pre-PCI era (between 1979 and 1996). 
PCI, percutaneous coronary intervention. 
  
 
Figure 9.  Prevalence of reperfusion therapy for AMI in male and female. 
The prevalence of primary PCI in female (71%, n=2,412) was significantly lower than in 
male (80%, n=6,061) (P<0.01). 
  
 
 
Figure 10.  The majority of AMI patients were hospitalized within 6 hours was fairly 
consistent throughout the study period. 
  
 
Figure 11.  The duration of hospital stay has been significantly shortened over the last 
30 years.  
The prevalence of discharge within 20 days after the onset of AMI significantly increased 
from 20% in 1979 to 66% in 2008 (P<0.0001).  
 
